Protara Therapeutics Inc. (NASDAQ: TARA) Stock Information | RedChip

Protara Therapeutics Inc. (NASDAQ: TARA) Listen to this Section


$2.07
+0.0150 ( +0.73% ) 186.9K

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Market Data


Open


$2.07

Previous close


$2.05

Volume


186.9K

Market cap


$41.47M

Day range


$2.00 - $2.12

52 week range


$1.04 - $5.24

Insider Ownership Transactions

Total Amount Purchased: -238,280.00 | $ -492,048.20

Date Type Amount Purchased Purchaser
2024-06-10 Sale -10000.00 Smith Cynthia
2024-06-10 Sale -10000.00 Levy Richard S
2024-06-10 Sale -10000.00 Flannelly Barry P
2024-05-31 Sale -9230.00 Opaleye Management Inc.
2024-05-23 Sale -31200.00 Opaleye Management Inc.
2024-05-17 Sale -47250.00 Opaleye Management Inc.
2024-05-10 Sale -30600.00 Opaleye Management Inc.
2024-01-23 Sale -59000.00 Shefferman Jesse
2024-01-23 Sale -23000.00 Zummo Jacqueline
2024-01-23 Sale -8000.00 Fry Hannah

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 May 31, 2024
4 Insider transactions 1 May 23, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.